secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001077183-25-000005
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics CEO Chris Smith to retire April 1; board member Tony Zook named successor
--------------------------------------------------------------------------------

- Chris Smith retires as CEO effective April 1, 2025; will serve as special advisor through Feb 2027 at $23,913/month.
- Tony Zook, independent board member since June 2023, appointed CEO effective April 1; base salary $850k with 100% target bonus and ~$8M annual equity target.
- Smith's retirement package includes pro-rated 2025 bonus, accelerated vesting of 265,452 restricted shares, and 12-month option exercise extension.
- Company reaffirms FY2024 guidance: revenue $655–$667M, net loss $(81)–$(78)M, adjusted EBITDA $37–$40M.
- NeoGenomics reported eight consecutive quarters of double-digit revenue growth under Smith's tenure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718325000005/0001077183-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718325000005/neo-20250103.htm
  HTML page:      https://secwatch.observer/filing/0001077183-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer